Investing.com - Surgery Partners Inc (NASDAQ: SGRY) reported third quarter EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $770.4M versus the consensus estimate of $768.99M.
Guidance
Surgery Partners Inc sees FY 2024 revenue of $3.08B versus the analyst consensus of $3.09B.
Surgery Partners Inc's stock price closed at $31.43. It is up 8.30% in the last 3 months and up 17.72% in the last 12 months.
Surgery Partners Inc saw 2 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Surgery Partners Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Surgery Partners Inc's Financial Health score is "great performance".
Check out Surgery Partners Inc's recent earnings performance, and Surgery Partners Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar